Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]
Public ClinicalTrials.gov record NCT02532621. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Evaluation of a Vascular Venous Anastomotic Connector for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis [InterGraft VIG-only Study]
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The InterGraft™ Venous Anastomotic Connector provides an endovascular, minimally invasive means for attachment of an arteriovenous graft to a vein in the upper extremity. The InterGraft™ Venous Anastomotic Connector facilitates creation of the arteriovenous graft connection to a vein in support of hemodialysis in subjects with End Stage Renal Disease. The InterGraft™ Venous Anastomotic Connector is used together with conventional suturing of the arterial anastomosis to facilitate creation of an arteriovenous graft in support of hemodialysis in subjects with End Stage Renal Disease.
Study identification
- NCT ID
- NCT02532621
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 158 participants
Conditions and interventions
Conditions
Interventions
- Venous InterGraft Connector Device
- sutured arterial anastomosis of an implanted vascular graft for hemodialysis Procedure
- hemodialysis Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2018 (Actual)
- Primary completion
- Jan 19, 2022 (Actual)
- Completion
- Jan 19, 2022 (Actual)
- Last update posted
- Feb 6, 2025
2018 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Triad of Alabama/Flowers Hospital | Dothan | Alabama | 36305 | — |
| Cartersville Medical Center, LLC | Cartersville | Georgia | 30120 | — |
| Medical Center of Central Georgia - Navicent Health | Macon | Georgia | 31201 | — |
| Henry Ford Health System- Dept of Surgery | Detroit | Michigan | 48202 | — |
| Saint Louis University | St Louis | Missouri | 63103 | — |
| Surgical Specialists of Charlotte | Charlotte | North Carolina | 28207 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| McLeod Physician Associates II | Florence | South Carolina | 29506 | — |
| Regional Medical Center of Orangeburg and Calhoun Counties | Orangeburg | South Carolina | 29118-1498 | — |
| Spartanburg Regional Medical Center | Spartanburg | South Carolina | 29303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02532621, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02532621 live on ClinicalTrials.gov.